Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Braz J Med Biol Res ; 38(9): 1349-57, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16138218

RESUMO

To evaluate the impact of electroconvulsive therapy on arterial blood pressure, heart rate, heart rate variability, and the occurrence of ischemia or arrhythmias, 38 (18 men) depressive patients free from systemic diseases, 50 to 83 years old (mean: 64.7 +/- 8.6) underwent electroconvulsive therapy. All patients were studied with simultaneous 24-h ambulatory blood pressure and Holter monitoring, starting 18 h before and continuing for 3 h after electroconvulsive therapy. Blood pressure, heart rate, heart rate variability, arrhythmias, and ischemic episodes were recorded. Before each session of electroconvulsive therapy, blood pressure and heart rate were in the normal range; supraventricular ectopic beats occurred in all patients and ventricular ectopic beats in 27/38; 2 patients had non-sustained ventricular tachycardia. After shock, systolic, mean and diastolic blood pressure increased 29, 25, and 24% (P < 0.001), respectively, and returned to baseline values within 1 h. Maximum, mean and minimum heart rate increased 56, 52, and 49% (P < 0.001), respectively, followed by a significant decrease within 5 min; heart rate gradually increased again thereafter and remained elevated for 1 h. Analysis of heart rate variability showed increased sympathetic activity during shock with a decrease in both sympathetic and parasympathetic drive afterwards. No serious adverse effects occurred; electroconvulsive therapy did not trigger any malignant arrhythmias or ischemia. In middle-aged and elderly people free from systemic diseases, electroconvulsive therapy caused transitory increases in blood pressure and heart rate and a decrease in heart rate variability but these changes were not associated with serious adverse clinical events.


Assuntos
Pressão Sanguínea/fisiologia , Eletroconvulsoterapia/métodos , Frequência Cardíaca/fisiologia , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Monitorização Ambulatorial da Pressão Arterial , Eletrocardiografia Ambulatorial , Eletroconvulsoterapia/efeitos adversos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
2.
Braz. j. med. biol. res ; 38(9): 1349-1357, Sept. 2005. tab, graf
Artigo em Inglês | LILACS | ID: lil-408362

RESUMO

To evaluate the impact of electroconvulsive therapy on arterial blood pressure, heart rate, heart rate variability, and the occurrence of ischemia or arrhythmias, 38 (18 men) depressive patients free from systemic diseases, 50 to 83 years old (mean: 64.7 ± 8.6) underwent electroconvulsive therapy. All patients were studied with simultaneous 24-h ambulatory blood pressure and Holter monitoring, starting 18 h before and continuing for 3 h after electroconvulsive therapy. Blood pressure, heart rate, heart rate variability, arrhythmias, and ischemic episodes were recorded. Before each session of electroconvulsive therapy, blood pressure and heart rate were in the normal range; supraventricular ectopic beats occurred in all patients and ventricular ectopic beats in 27/38; 2 patients had non-sustained ventricular tachycardia. After shock, systolic, mean and diastolic blood pressure increased 29, 25, and 24 percent (P < 0.001), respectively, and returned to baseline values within 1 h. Maximum, mean and minimum heart rate increased 56, 52, and 49 percent (P < 0.001), respectively, followed by a significant decrease within 5 min; heart rate gradually increased again thereafter and remained elevated for 1 h. Analysis of heart rate variability showed increased sympathetic activity during shock with a decrease in both sympathetic and parasympathetic drive afterwards. No serious adverse effects occurred; electroconvulsive therapy did not trigger any malignant arrhythmias or ischemia. In middle-aged and elderly people free from systemic diseases, electroconvulsive therapy caused transitory increases in blood pressure and heart rate and a decrease in heart rate variability but these changes were not associated with serious adverse clinical events.


Assuntos
Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pressão Sanguínea/fisiologia , Eletroconvulsoterapia/métodos , Frequência Cardíaca/fisiologia , Análise de Variância , Monitorização Ambulatorial da Pressão Arterial , Eletrocardiografia Ambulatorial , Eletroconvulsoterapia/efeitos adversos
3.
Psiquiatr. biol ; 7(1): 3-6, 1999. tab
Artigo em Português | LILACS | ID: lil-255542

RESUMO

Este estudo com a nefazodona, um novo inibidor seletivo de recaptaçäo de serotonina(ISRS), tem o objetivo maior de mostrar o perfil de interaçöes medicamentosas, droga com droga, assim como com o CYP-450, mostrando os principais efeitos colaterais e açöes terapêuticas principais


Assuntos
Humanos , Masculino , Feminino , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Sistema Enzimático do Citocromo P-450/uso terapêutico , Depressão/dietoterapia , Depressão/psicologia , Depressão/terapia
4.
Psiquiatr. biol ; 6(3): 139-44, set. 1998. tab
Artigo em Português | LILACS | ID: lil-225681

RESUMO

Este artigo tem o escopo de mostrar a moclobemida, um inibidor reversível da MAOA apresenta um baixo perfil de interaçöes medicamentosas, principalmente no que tange à farmacodinâmica ocupando lugar de destaque na prática clínica para o tratamento de depressäo e alguns transtornos ansiosos


Assuntos
Humanos , Animais , Adulto , Transtornos de Ansiedade/terapia , Depressão/terapia , Inibidores da Monoaminoxidase/farmacocinética , Inibidores da Monoaminoxidase/farmacologia , Inibidores da Monoaminoxidase/uso terapêutico , Antidepressivos/farmacologia , Psicotrópicos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA